This PCR and Realtime PCR Testing market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.
The PCR and realtime PCR testing market size has grown strongly in recent years. It will grow from $10.55 billion in 2024 to $11.21 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to disease diagnosis, research and genomic studies, automation and high throughput, pharmaceutical and biotechnology applications, point-of-care testing.
The PCR and realtime PCR testing market size is expected to see strong growth in the next few years. It will grow to $15.39 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to pandemic response, precision medicine, cancer diagnostics, infectious disease surveillance. Major trends in the forecast period include infectious disease testing, point-of-care testing, digital pcr, multiplex assays.
The early detection of COVID-19 is a crucial factor in effectively treating patients. Among the various testing methods available, real-time RT-PCR stands out as a highly sensitive and specific technique that can provide a reliable diagnosis in as little as three hours, significantly faster than other laboratory tests, which typically take an average of 6 to 8 hours. Real-time RT-PCR is not only quicker but also has a lower risk of contamination or errors since the entire process occurs within a closed tube. As a result, it is currently considered the most accurate method for detecting the COVID-19. This has led to a substantial increase in demand for PCR testing kits, driving the market's growth.
The increasing approvals for personalized medicines are expected to drive the growth of the PCR and real-time PCR testing market. Personalized medicines are treatments specifically designed for individual patients, based on their genetic, biomarker, phenotypic, or psychosocial characteristics, which can predict how they will respond to a particular treatment. PCR and real-time PCR testing play a critical role in personalized medicine by accurately identifying genetic variations, enabling treatments to be tailored to each patient’s unique needs for optimal therapeutic outcomes. For example, in February 2024, the Personalized Medicine Coalition reported that in 2023, the FDA approved 16 new personalized treatments for rare disease patients, a significant increase from six in 2022. As a result, the growing approval of personalized medicines is expected to boost the demand for PCR and real-time PCR testing.
Companies operating in the PCR and real-time PCR testing market are continuously innovating by introducing new test kits and systems for diagnosing various diseases. In January 2022, BioGenex Life Sciences Pvt Ltd developed an RT-PCR kit for COVID-19 diagnosis. This kit can identify COVID-19 caused by different SARS-CoV-2 strains, including 'OmicronON,' without the need for RNA extraction and does so twice as quickly as conventional PCR tests. Many companies are introducing real-time RT-PCR tests for COVID-19, contributing to the market's growth.
Major companies in the PCR and real-time PCR testing market are focused on developing advanced diagnostic tools to meet market demands and client needs. A real-time reverse transcription-polymerase chain reaction (RT-PCR) detection kit is a diagnostic tool used to detect specific RNA sequences. For instance, in May 2022, Mylab Discovery Solutions, an India-based diagnostics company, launched the Discover Series HLAB*27 Detection Kit, an advanced RT-PCR diagnostic instrument designed for the early detection of Ankylosing Spondylitis, an inflammatory condition primarily affecting the spine. This kit is crucial for individuals genetically susceptible to the condition, as HLA-B27 is found in approximately 90% of patients. Using real-time PCR technology, the kit offers nearly 100% accuracy, outperforming many other kits in the market by covering a wide range of known genotypes and subtypes.
Major companies operating in the pcr and realtime pcr testing market include Abbott Laboratories, Agilent Technologies Inc., bioMérieux SA, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., QIAGEN N.V., GenMark Diagnostics Inc., Thermo Fisher Scientific Inc., General Electric Company, Danaher Corporation, Becton Dickinson and Company, Luminex Corporation, Meridian Bioscience Inc., Fluidigm Corporation, RainDance Technologies Inc., BioFire Diagnostics LLC, Cepheid Inc., Illumina Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Promega Corporation, Takara Bio Inc., Twist Bioscience Corporation, Zymo Research Corporation, BioChain Institute Inc., BioLegend Inc., Bioo Scientific Corporation, Creative Diagnostics, Eurofins Scientific SE, Myriad Genetics Inc.
Polymerase chain reaction (PCR) and real-time polymerase chain reaction (PCR) tests are widely used techniques for detecting and quantifying DNA (or RNA) in a given sample. These tests are typically carried out in automated thermal cyclers, which are designed to minimize the risk of cross-contamination. PCR and real-time PCR have various applications in fields such as cloning, genotyping, mutation testing, paternity testing, sequencing, and microarrays.
The primary products associated with PCR and real-time PCR testing include consumables, reagents, instruments, software, and various services. These tests leverage technologies such as quantitative PCR and digital PCR, which offer a range of applications in clinical diagnostics, life science research, industrial settings, and other fields. The market for PCR and real-time PCR testing is segmented by end-use, which includes academic and research institutes, pharmaceutical and biotechnology companies, clinical diagnostics labs and hospitals, and other entities.
The PCR and real-time PCR testing market research report is one of a series of new reports that provides PCR and real-time PCR testing market statistics, including polymerase chain reaction PCR and real-time PCR testing industry global market size, regional shares, competitors with a polymerase chain reaction PCR and real-time PCR testing market share, detailed PCR and real-time PCR testing market segments, market trends and opportunities, and any further data you may need to thrive in the PCR and real-time PCR testing industry. This polymerase chain reaction PCR and real-time PCR testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Asia-Pacific was the largest region in the PCR and real-time PCR testing market in 2024. Western Europe was the second-largest region in the PCR and real-time PCR testing market. The regions covered in the pcr and realtime pcr testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pcr and realtime pcr testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
The PCR and Real-time PCR testing market consists of sales of genetic sequencing equipment such as automated thermo cyclers with technologies such as quantitative PCR and digital PCR for cloning, genotyping, mutation testing, paternity testing, sequencing, and microarrays. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The PCR and realtime PCR testing market size has grown strongly in recent years. It will grow from $10.55 billion in 2024 to $11.21 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to disease diagnosis, research and genomic studies, automation and high throughput, pharmaceutical and biotechnology applications, point-of-care testing.
The PCR and realtime PCR testing market size is expected to see strong growth in the next few years. It will grow to $15.39 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to pandemic response, precision medicine, cancer diagnostics, infectious disease surveillance. Major trends in the forecast period include infectious disease testing, point-of-care testing, digital pcr, multiplex assays.
The early detection of COVID-19 is a crucial factor in effectively treating patients. Among the various testing methods available, real-time RT-PCR stands out as a highly sensitive and specific technique that can provide a reliable diagnosis in as little as three hours, significantly faster than other laboratory tests, which typically take an average of 6 to 8 hours. Real-time RT-PCR is not only quicker but also has a lower risk of contamination or errors since the entire process occurs within a closed tube. As a result, it is currently considered the most accurate method for detecting the COVID-19. This has led to a substantial increase in demand for PCR testing kits, driving the market's growth.
The increasing approvals for personalized medicines are expected to drive the growth of the PCR and real-time PCR testing market. Personalized medicines are treatments specifically designed for individual patients, based on their genetic, biomarker, phenotypic, or psychosocial characteristics, which can predict how they will respond to a particular treatment. PCR and real-time PCR testing play a critical role in personalized medicine by accurately identifying genetic variations, enabling treatments to be tailored to each patient’s unique needs for optimal therapeutic outcomes. For example, in February 2024, the Personalized Medicine Coalition reported that in 2023, the FDA approved 16 new personalized treatments for rare disease patients, a significant increase from six in 2022. As a result, the growing approval of personalized medicines is expected to boost the demand for PCR and real-time PCR testing.
Companies operating in the PCR and real-time PCR testing market are continuously innovating by introducing new test kits and systems for diagnosing various diseases. In January 2022, BioGenex Life Sciences Pvt Ltd developed an RT-PCR kit for COVID-19 diagnosis. This kit can identify COVID-19 caused by different SARS-CoV-2 strains, including 'OmicronON,' without the need for RNA extraction and does so twice as quickly as conventional PCR tests. Many companies are introducing real-time RT-PCR tests for COVID-19, contributing to the market's growth.
Major companies in the PCR and real-time PCR testing market are focused on developing advanced diagnostic tools to meet market demands and client needs. A real-time reverse transcription-polymerase chain reaction (RT-PCR) detection kit is a diagnostic tool used to detect specific RNA sequences. For instance, in May 2022, Mylab Discovery Solutions, an India-based diagnostics company, launched the Discover Series HLAB*27 Detection Kit, an advanced RT-PCR diagnostic instrument designed for the early detection of Ankylosing Spondylitis, an inflammatory condition primarily affecting the spine. This kit is crucial for individuals genetically susceptible to the condition, as HLA-B27 is found in approximately 90% of patients. Using real-time PCR technology, the kit offers nearly 100% accuracy, outperforming many other kits in the market by covering a wide range of known genotypes and subtypes.
Major companies operating in the pcr and realtime pcr testing market include Abbott Laboratories, Agilent Technologies Inc., bioMérieux SA, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., QIAGEN N.V., GenMark Diagnostics Inc., Thermo Fisher Scientific Inc., General Electric Company, Danaher Corporation, Becton Dickinson and Company, Luminex Corporation, Meridian Bioscience Inc., Fluidigm Corporation, RainDance Technologies Inc., BioFire Diagnostics LLC, Cepheid Inc., Illumina Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Promega Corporation, Takara Bio Inc., Twist Bioscience Corporation, Zymo Research Corporation, BioChain Institute Inc., BioLegend Inc., Bioo Scientific Corporation, Creative Diagnostics, Eurofins Scientific SE, Myriad Genetics Inc.
Polymerase chain reaction (PCR) and real-time polymerase chain reaction (PCR) tests are widely used techniques for detecting and quantifying DNA (or RNA) in a given sample. These tests are typically carried out in automated thermal cyclers, which are designed to minimize the risk of cross-contamination. PCR and real-time PCR have various applications in fields such as cloning, genotyping, mutation testing, paternity testing, sequencing, and microarrays.
The primary products associated with PCR and real-time PCR testing include consumables, reagents, instruments, software, and various services. These tests leverage technologies such as quantitative PCR and digital PCR, which offer a range of applications in clinical diagnostics, life science research, industrial settings, and other fields. The market for PCR and real-time PCR testing is segmented by end-use, which includes academic and research institutes, pharmaceutical and biotechnology companies, clinical diagnostics labs and hospitals, and other entities.
The PCR and real-time PCR testing market research report is one of a series of new reports that provides PCR and real-time PCR testing market statistics, including polymerase chain reaction PCR and real-time PCR testing industry global market size, regional shares, competitors with a polymerase chain reaction PCR and real-time PCR testing market share, detailed PCR and real-time PCR testing market segments, market trends and opportunities, and any further data you may need to thrive in the PCR and real-time PCR testing industry. This polymerase chain reaction PCR and real-time PCR testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Asia-Pacific was the largest region in the PCR and real-time PCR testing market in 2024. Western Europe was the second-largest region in the PCR and real-time PCR testing market. The regions covered in the pcr and realtime pcr testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pcr and realtime pcr testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
The PCR and Real-time PCR testing market consists of sales of genetic sequencing equipment such as automated thermo cyclers with technologies such as quantitative PCR and digital PCR for cloning, genotyping, mutation testing, paternity testing, sequencing, and microarrays. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. PCR and Realtime PCR Testing Market Characteristics3. PCR and Realtime PCR Testing Market Trends and Strategies4. PCR and Realtime PCR Testing Market - Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, and the Recovery from COVID-19 on the Market32. Global PCR and Realtime PCR Testing Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the PCR and Realtime PCR Testing Market34. Recent Developments in the PCR and Realtime PCR Testing Market
5. Global PCR and Realtime PCR Testing Growth Analysis and Strategic Analysis Framework
6. PCR and Realtime PCR Testing Market Segmentation
7. PCR and Realtime PCR Testing Market Regional and Country Analysis
8. Asia-Pacific PCR and Realtime PCR Testing Market
9. China PCR and Realtime PCR Testing Market
10. India PCR and Realtime PCR Testing Market
11. Japan PCR and Realtime PCR Testing Market
12. Australia PCR and Realtime PCR Testing Market
13. Indonesia PCR and Realtime PCR Testing Market
14. South Korea PCR and Realtime PCR Testing Market
15. Western Europe PCR and Realtime PCR Testing Market
16. UK PCR and Realtime PCR Testing Market
17. Germany PCR and Realtime PCR Testing Market
18. France PCR and Realtime PCR Testing Market
19. Italy PCR and Realtime PCR Testing Market
20. Spain PCR and Realtime PCR Testing Market
21. Eastern Europe PCR and Realtime PCR Testing Market
22. Russia PCR and Realtime PCR Testing Market
23. North America PCR and Realtime PCR Testing Market
24. USA PCR and Realtime PCR Testing Market
25. Canada PCR and Realtime PCR Testing Market
26. South America PCR and Realtime PCR Testing Market
27. Brazil PCR and Realtime PCR Testing Market
28. Middle East PCR and Realtime PCR Testing Market
29. Africa PCR and Realtime PCR Testing Market
30. PCR and Realtime PCR Testing Market Competitive Landscape and Company Profiles
31. PCR and Realtime PCR Testing Market Other Major and Innovative Companies
35. PCR and Realtime PCR Testing Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
PCR and Realtime PCR Testing Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on pcr and realtime pcr testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for pcr and realtime pcr testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pcr and realtime pcr testing market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include: the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Product: Consumables and Reagents; Instruments; Software and Services2) By Technology: Quantitative PCR; Digital PCR
3) By Application: Clinical Diagnostics; Life Science Research; Industrial Applications; Other Applications
4) By End-Use: Academic and Research Institutes; Pharmaceutical and Biotechnology; Clinical Diagnostics Labs and Hospitals; Other End Users
Subsegments:
1) By Consumables and Reagents: PCR Reagents; PCR Kits; PCR Primers and Probes; DNA and RNA Extraction Kits2) By Instruments: PCR Machines/Amplifiers; Real-Time PCR Systems; Thermal Cyclers; Automated PCR Systems
3) By Software and Services: Data Analysis Software; PCR Software; Maintenance and Support Services; Training Services
Key Companies Mentioned: Abbott Laboratories; Agilent Technologies Inc.; bioMérieux SA; Bio-Rad Laboratories Inc.; F. Hoffmann-La Roche Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
The major companies featured in this PCR and Realtime PCR Testing market report include:- Abbott Laboratories
- Agilent Technologies Inc.
- bioMérieux SA
- Bio-Rad Laboratories Inc.
- F. Hoffmann-La Roche Ltd.
- QIAGEN N.V.
- GenMark Diagnostics Inc.
- Thermo Fisher Scientific Inc.
- General Electric Company
- Danaher Corporation
- Becton Dickinson and Company
- Luminex Corporation
- Meridian Bioscience Inc.
- Fluidigm Corporation
- RainDance Technologies Inc.
- BioFire Diagnostics LLC
- Cepheid Inc.
- Illumina Inc.
- Oxford Nanopore Technologies Ltd.
- Pacific Biosciences of California Inc.
- Promega Corporation
- Takara Bio Inc.
- Twist Bioscience Corporation
- Zymo Research Corporation
- BioChain Institute Inc.
- BioLegend Inc.
- Bioo Scientific Corporation
- Creative Diagnostics
- Eurofins Scientific SE
- Myriad Genetics Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 175 |
| Published | April 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 11.21 Billion |
| Forecasted Market Value ( USD | $ 15.39 Billion |
| Compound Annual Growth Rate | 8.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 31 |
